2024
What Happens Next? Maintenance of Gains After Discharge From VA Residential PTSD Treatment
Grau P, Harpaz-Rotem I, Ilgen M, Ganoczy D, Sripada R. What Happens Next? Maintenance of Gains After Discharge From VA Residential PTSD Treatment. The Journal Of Nervous And Mental Disease 2024, 212: 197-204. PMID: 38536046, DOI: 10.1097/nmd.0000000000001749.Peer-Reviewed Original ResearchMeSH KeywordsHumansLogistic ModelsOdds RatioPatient DischargeResidential TreatmentStress Disorders, Post-TraumaticConceptsMaintenance of gainsResidential PTSD treatmentPosttraumatic stress disorderPTSD treatmentStress disorderResidential treatmentSymptom reboundDepartment of Veterans AffairsCohort of veteransSignificant respondersTreatment responseNational cohort of veteransVeteransAssociated with maintenanceResponse profilesPain severityVeterans AffairsGreater pain severitySessionsAssociated with decreased oddsPsychotherapyAssociated with increased oddsSeverityDisordersRespondents
2018
Protective correlates of suicidality among veterans with histories of posttraumatic stress disorder and major depressive disorder: Results from the National Health and Resilience in Veterans Study
Kachadourian LK, Tsai J, Harpaz-Rotem I, Southwick SM, Pietrzak RH. Protective correlates of suicidality among veterans with histories of posttraumatic stress disorder and major depressive disorder: Results from the National Health and Resilience in Veterans Study. Journal Of Affective Disorders 2018, 246: 731-737. PMID: 30616162, DOI: 10.1016/j.jad.2018.12.058.Peer-Reviewed Original ResearchMeSH KeywordsAdultCross-Sectional StudiesDepressive Disorder, MajorFemaleHumansLogistic ModelsMaleMiddle AgedMultivariate AnalysisOptimismPrevalenceProtective FactorsResilience, PsychologicalRisk FactorsStress Disorders, Post-TraumaticSuicidal IdeationSuicideSuicide, AttemptedSurveys and QuestionnairesUnited StatesVeteransYoung AdultConceptsMajor depressive disorderPosttraumatic stress disorderProtective correlatesSuicidal ideationSuicide attemptsProtective factorsDepressive disorderNational HealthVeterans StudyMultivariable logistic regression analysisSuicidal behaviorStress disorderHistory of PTSDLogistic regression analysisSample of veteransAssessment of suicidalityLifetime suicide attemptsRisk factorsHigh-risk sampleTreatment approachesU.S. veteransWeb-based surveyCross-sectional natureSuicide riskSelf-report items
2013
Predominant typologies of psychopathology in the United States: A latent class analysis
El-Gabalawy R, Tsai J, Harpaz-Rotem I, Hoff R, Sareen J, Pietrzak RH. Predominant typologies of psychopathology in the United States: A latent class analysis. Journal Of Psychiatric Research 2013, 47: 1649-1657. PMID: 23978394, DOI: 10.1016/j.jpsychires.2013.07.028.Peer-Reviewed Original ResearchConceptsPopulation-based sampleSubstance use disordersAxis IU.S. adultsLatent class analysisUse disordersSuicide attemptsMental health-related qualityHealth-related qualityLifetime psychiatric disordersRates of moodAxis II disordersNational Epidemiologic SurveyPsychiatric comorbidityOverall high ratePsychiatric disordersEpidemiologic SurveyComorbid classesMental disordersClass analysisRelated conditionsAnxiety disordersBorderline/Personality disorderDisorders
2012
Psychotherapy use in a privately insured population of patients diagnosed with a mental disorder
Harpaz-Rotem I, Libby D, Rosenheck RA. Psychotherapy use in a privately insured population of patients diagnosed with a mental disorder. Social Psychiatry And Psychiatric Epidemiology 2012, 47: 1837-1844. PMID: 22349151, DOI: 10.1007/s00127-012-0486-9.Peer-Reviewed Original ResearchMeSH KeywordsAdultAnxiety DisordersComorbidityDatabases as TopicDepressive Disorder, MajorFemaleHealth Care SurveysHumansInsurance CoverageInsurance, HealthLogistic ModelsMaleMental DisordersMental Health ServicesMiddle AgedPrivate SectorPsychotherapyStress Disorders, Post-TraumaticTreatment OutcomeUnited StatesConceptsMajor depressive disorderUse of psychotherapyPosttraumatic stress disorderReceipt of psychotherapyPsychotherapy visitsDepressive disorderMild depressionBipolar disorderMental disordersStress disorderAlcohol useCorrelates of receiptCurrent Procedural Terminology codesPopulation of patientsLarge claims databaseAlternative drug therapiesProcedural Terminology codesMental health servicesMultivariate binary regressionEffectiveness of psychotherapyPatient characteristicsClaims databasePharmacological treatmentDrug therapyPsychotherapy use
2009
Duration of Pharmacotherapy with Long-Acting Injectable Risperidone in the Treatment of Schizophrenia
Mohamed S, Rosenheck R, Harpaz-Rotem I, Leslie D, Sernyak MJ. Duration of Pharmacotherapy with Long-Acting Injectable Risperidone in the Treatment of Schizophrenia. Psychiatric Quarterly 2009, 80: 241-249. PMID: 19768543, DOI: 10.1007/s11126-009-9111-9.Peer-Reviewed Original ResearchConceptsSecond-generation antipsychoticsInjectable risperidoneLong-Acting Injectable RisperidoneDuration of pharmacotherapyOral conventional antipsychoticsHalf of patientsMultivariable logistic regressionTreatment of schizophreniaDuration of treatmentProportional hazards modelOral antipsychoticsTreatment discontinuationOral medicationsReal-world practiceConventional antipsychoticsPatient characteristicsMedication adherenceAntipsychotic medicationVA patientsHazards modelAntipsychoticsMedicationsPatientsLogistic regressionRisperidone
2008
Pharmacologic Treatment of Posttraumatic Stress Disorder Among Privately Insured Americans
Harpaz-Rotem I, Rosenheck RA, Mohamed S, Desai RA. Pharmacologic Treatment of Posttraumatic Stress Disorder Among Privately Insured Americans. Psychiatric Services 2008, 59: 1184-1190. PMID: 18832505, DOI: 10.1176/ps.2008.59.10.1184.Peer-Reviewed Original ResearchConceptsPosttraumatic stress disorderPsychotropic medicationsMedication classesStress disorderTreatment of PTSDMental health care usersSymptom-specific responsesComorbid psychiatric disordersUse of anxiolyticsMultivariate logistic regressionDiagnosis of PTSDMajor depressive disorderMental health servicesHealth care usersMedication usePharmacologic treatmentAntidepressant useHealth insurance plansMarketScan databaseAntipsychotic usePrivate health insurance plansPharmacological treatmentDepressive disorderSpecific symptomsMillions of Americans